InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Malabre Richard C. Director active across 1 company, notably Akebia Therapeutics, Inc.. In total, 6 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €84k. History available since 31 January 2024. The latest transaction was disclosed on 2 February 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Malabre Richard C is a declarant linked to Akebia Therapeutics, Inc. on XNAS. Across 6 filings in total, the 6 sampled filings cover the period from 2024-02-02 to 2026-02-04, with EUR 0 in buys and EUR 83606 in sells, and the most frequent transaction nature is Attribution.